Liver-enriched transcription factors and their role in regulating UDP glucuronosyltransferase gene expression.
Variations in the capacity to detoxify carcinogens and other environmental toxins, and to eliminate drugs and waste products of metabolism, are likely to have significant effects on health and drug efficacy. As the UDP glucuronosyltransferases metabolize many of these substances to less toxic glucuronides, variations in UGT expression are likely to be important in maintenance of health and therapeutic outcomes. The factors that regulate UGT gene expression are beginning to be identified. From among these factors, the Liver-Enriched Transcription Factors (LETFs), including Hepatocyte Nuclear Factors 1 and 4alpha, have a major role in UGT regulation in the major sites of drug metabolism, the liver and gastrointestinal tract. This review will describe what is currently known about these LETFs and their role in UGT gene expression. It is likely that polymorphisms in LETFs and the sites to which they bind in UGT genes, may impact on drug induced disease and drug therapy.
Gardner-Stephen
D A
DA
Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide 5042, Australia.
Mackenzie
P I
PI
D000595:Amino Acid Sequence; D000818:Animals; D014453:Glucuronosyltransferase / Q000096:biosynthesis* / Q000235:genetics*; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008969:Molecular Sequence Data; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism*
D014157:Transcription Factors; D014453:Glucuronosyltransferase